Thursday, December 07, 2017

Movie 'First, do no harm', epilepsy and ketogenic diet cuttings

Movie First do no harm https://en.wikipedia.org/wiki/...First_Do_No_Harm



https://www.charliefoundation.org/who-we-are/who-2/about-the-foundation

https://ketocook.com/

https://web.archive.org/web/20080213122107/http://www.charliefoundation.org/noframes/whoweare/essay.php

'In: THE KETOGENIC DIET IN EPILEPSY: CLINICAL PRACTICE AND SCIENTIFIC
BASIS, C.E. Stafstrom, J. M. Rho (Editors), Humana Press 2004, Totowa, NJ

*AFTERWORD
"Things I Wish They Had Told Us: A Parent's Perspective on Childhood
Epilepsy"
*Jim Abrahams
The Charlie Foundation
/"IMPRESSION: It is my impression that Charlie has a mixed seizure disorder, mostly likely a variation of Lennox-Gastaut syndrome. Parents are full aware of the ramifications of this diagnosis. Although there are many traditional combinations and permutations of drugs that could be used here, I agree with the current approach. It is my understandin that the next drug to be tried is a combination of Felbamate and Tegretol with which I have no problem. I would also consider the combination of Felbamate with Valproate with perhaps a benzodiazepine. In addition, one wonders if the Felbamate could be pushed to an eve higher dose than it is now, since we really do not know what the maximum dose of Felbamate is in young children. Another possibility is high-dose Valproate monotherapy. One other alternative therapy which I have mentioned to the family, but only reluctantly because of the high
incidence of side-effects is high-dose ACTH. The problem is that while high-dose ACTH may be effective in stopping the seizures, they almost
always recur as the dose is tapered. This makes one wonder if the risk-benefit ratio justifies the use of this somewhat dangerous mode of therapy. Finally think that if all pharmacological or theraputic modalities fail, I would seriously consider a corpus callosotomy on this child. A corpus callosotomy would not be curative of all the seizure types, but may help the most troublesome part of his seizure complex, i.e. the "drops.”
I excerpted the above from a medical report we received on our son, Charlie. It’s not really necessary to mention the name of the doctor who wrote it. Suffice it to say he was the fifth pediatric neurologist my wife and I had taken Charlie to see in the year he had been experiencing seizures -- four of whom ran pediatric neurology departments at esteemed university hospitals around the United States. They all concurred. Yes, there were some variations in drug
combinations suggested, and I’m sure that to a certain extent this report dates itself in that there are new drugs available today. But the reason I begin with this “impression” is not so much for what it says, but rather for what it doesn’t -- what it and all the doctors who examined Charlie never told us.
Today, nine years later, I think back to those days, and realize how much time was lost, how much unnecessary damage was done to Charlie’s life, and as a result, how much needless pain was, and continues to be, experienced by Charlie and all of us who love him -- all because information was not shared. I know the value of “ifs,” but sometimes I can’t help myself: If only the first time we walked into a neurologist’s office someone had handed us a pamphlet, recommended a book or taken the time to tell us just some of the following information we have learned since then...
Treating kids with difficult to control seizures is 20% science and 80% art. It was not long after we received the above doctor’s report that I was watching a CNN report on childhood epilepsy and there was one of the doctors who had seen Charlie making that statement. (Actually the statistic he used was “10 % science and 90% art,” but since then I’ve put the art versus science question to many neurologists and none peg it lower than 75% art, so I’ve rounded the number down). “Hold on a second,” I thought when I heard the CNN broadcast. Those were lab coats Charlie’s doctors were wearing, not smocks to protect them from splattering paint! They were scientists! Interior decorating is an art form -- not pediatric neurology. In discussing the subject with me, a world-renowned pediatric neurologist likened treating difficult cases to fishing. Just as you return to one fishing hole time and again after you’ve had luck once, so too a neurologist will return to the same drug combination time and again after one success. To a parent, this is a big deal. Clearly it puts the onus on the parent of the sick child to ask a key question, “Based on what?” “Based on what information are you telling me this, doctor?” Similarly I believe it puts a duty on the doctor to advise a patient if he is basing a statement on anecdote, experience, or science. An example: Lennox Gasteau Syndrome features the full gamut of seizure types. Charlie suffered most of them -- including tonic-clonic seizures. We were instructed at the time by his doctors that a tonic-clonic seizure, if allowed to continue for over thirty minutes, could damage his young brain. Therefore, at thirty minutes, drug intervention with Valium or Ativan would be necessary. We lived ten minutes from a hospital. So,whenever Charlie would begin one of his many tonic-clonic seizures, the first thing we did was to make note of the time. Twenty minutes into the seizure we’d get into the car and take off for the hospital. Certainly, as we sat there trying to comfort him during his many tonic-clonic seizures, every parental instinct in us told us that these prolonged
misfirings of his brain had to be damaging and we should put a stop to them earlier if possible. But we were typical, terrified parents and never questioned from whence the magical thirty minutes came. We never asked, “Based on what?” Several years later, after Charlie’s seizures were controlled by the ketogenic diet, and when both his physical and mental delays were apparent, I attended an epilepsy conference and learned the
thirty-minute rule had been shortened to five minutes. Now tonic-clonic seizures could damage the brain in five minutes. All those hours of
holding him when we could have stopped his seizures had in fact been detrimental to Charlie. The thirty-minute rule was not scientific.
There were no blinded studies documenting the long-term effects oftonic-clonic seizures of more or less than thirty minutes. At best, the
thirty-minute rule was based on anecdote, and at worst it was based on lore. I wish that someone had told us. I wish we had known the art versus science percentage. I wish we had asked, “Based on what?” There’s no science behind it. This was an argument selectively used by several physicians who saw Charlie. Monotherapy, then multiple drugs, and finally a surgery failed to slow his seizures. He started to lose abilities he once had and, like most parents, we became more desperate. Holistic approaches, Chinese herbs, neck re-alignment and a host of non-Western approaches were suggested. The medical argument against them was: no science. I’d have no problem with that notion were it spread evenly across the playing field. But it’s not. From the naive patient’s point of view, when that argument is used to overrule “non-traditional” therapies, but omitted from Western recommendations, there is the assumption that Western approaches are backed by science. So, for example, when Dilantin was added to Charlie’s daily Felbatol, Tegretol, and benzodiazapine, in the absence of any cautionary thought regarding “no science,” I wrongly assumed (and probably never questioned) that modern science was at work. Nancy and I dutifully coerced Charlie into swallowing all that stuff around the clock and watched the terrible side-effects. Far from our minds was the notion he might be a guinea pig. If not a “crap shoot,” the chance of this drug combo stopping even some of his seizures and leaving him with any acceptable quality of life was beyond remote. What’s more, the effects of the simultaneous use of these potent drugs on his one year-old brain was and is completely without scientific documentation. We assumed naively that if there were no medical books
on the interactions and efficacy of that combination of drugs, certainly there were articles. As a matter of fact, I came to learn, there is no hard science regarding efficacy or side- effects behind any multiple drug combinations in the treatment of pediatric epilepsy. Again, my problem is more than trying multiple drug combinations. What I wish they had told us is that the “there’s no science behind it” argument is used to dissuade us from some approaches and omitted from others at the doctor's discretion. Seventy percent of new epilepsy patients have their seizures controlled with the first anti-epileptic drug they try -- almost irrespective of which drug it is. After the first drug fails, there is a 10% to 15% chance the second drug will work and only a 20 % chance drugs will ever control a child’s seizures. In other words, after a second anti-epileptic drug fails, four out of five children will not achieve seizure control with drugs alone. I’ve been told by some that this fact, were it known by many parents, would rob them of hope. I disagree. If someone had told us, it would have robbed us of complacency.
_A Couple of Drug Facts
1) The minimum criterion for the FDA to approve a new anti-epileptic drug, assuming the drug’s side-effects are not prohibitive, is that the drug stops 50% of the seizures in at least 50% of the children (who do not drop out of the study because of intolerance, noncompliance, or other reasons). In other words, if one hundred kids test a new drug and twenty-five drop out of the study, thirty-eight must have at least a fifty percent reduction in seizures. There is no requirement for a new drug to stop seizures to be approved by the FDA. For parent of a child with difficult-to-control seizures, there is always the "buzz," the promise about the next drug -- the next "great White hope" -- to arrive on the market. Very few of us know this liberal criterion for FDA approval.
2) In 1993, a new drug, Felbatol, met those requirements and was approved by the FDA for children with difficult-to-control seizures. It was produced by a company named Carter-Wallace. I wrote to Carter-Wallace to get their annual stock holders report. From this report, it was clear that in the two years prior to the release of Felbatol, the company spent $20,000,000 -- not on research and development, but on marketing the drug. In 1993, there were about twelve hundred pediatric neurologists in the U.S. to whom their advertising campaign was aimed. I’ll let you do the math. Twenty million dollars to convince twelve hundred folks to prescribe a drug! I certainly wish someone had told us that bit of information before we allowed Charlie to spend all those sleepless nights while he was on Felbatol, without helping his seizure control.
Legal Standard of Care Regarding Provision of Information
The legal standard of care in America today, with regard to a physician sharing information with a patient, is that the physician isrequired to tell his patient, in general, the same information his colleagues would share with their patients under similar circumstances. Practically speaking, that means that if, in a court of law, a doctor can get several other doctors to testify that they would have informed their patients similarly to the way he informed his patient, he has
conformed to the standard of care. This is not to suggest that legalities were ever a consideration regarding Charlie’s case; it is only to provide information I wish I had had, the bottom line regarding information-sharing by a physician. As his dad, especially in a case like Charlie’s where his seizures were difficult-to-control and the art versus science thing was clearly applicable, I always assumed our doctors would lay out a range of treatments and together we would decide on the correct course of action -- in essence, a doctor/patient partnership. I assumed an informed joint decision-making process. I was wrong. Certainly we didn’t pretend to have the medical expertise, but then
of course the doctors didn’t live with Charlie, and had no real knowledge of his family, its agony, and his living circumstances. And of course none of the doctors we saw had ever held their own child during a seizure. Unfortunately, informed joint decision-making turned out to be wishful thinking. Information was always provided on a need-to-know basis and then in a seemingly reluctant manner. In fact, there was almost a physical chill when more than limited probing and suggesting occurred.
The Ketogenic Diet
Throughout Charlie's epilepsy, I remember crying hardest with Nancy when we received the copy of the above report. It seemed so hopeless. And yes, we were “fully aware of the ramifications” of Charlie’s diagnosis. So, as a way to prepare Charlie and the rest of us for what seemed to be many more years of seizures drugs and “progressive retardation,” I started doing some research. To my surprise, in epilepsy texts dating back to the 1920’s (and in every decade from the 20’s through the present) from Hopkins, the Mayo Clinic and many other highly regarded institutions, there was consistent anecdotal documentation regarding the ketogenic diet and its efficacy (roughly one-third of the kids who tried it became seizure-free, one-third were
significantly improved and for one-third it was ineffective). The documentation totaled literally thousands of children with epilepsy. In addition, the diet’s side-effects were minimal compared to many of those that Charlie had experienced. I learned that there was still a dietician at Johns Hopkins who had forty plus years of experience with the diet. So, one month after receiving that gloomy report, we took Charlie to Johns Hopkins. They put him on the diet. His seizures dropped from dozens a day to zero within forty-eight hours of its initiation, and he was off all medication in another month.
I don’t want to minimize the difficulty of the diet, but it was a walk on the beach next to the drugs and continued seizure activity. More importantly, we had our son back! Today Charlie is eleven years old, off the diet, and has been seizure- and drug-free for years. I asked his doctors why they left it to us to learn about the diet they all had heard of. Their answers: 1) it was too difficult; 2) being high in fat, it may be unhealthy; and 3) there was no science behind the diet. Too difficult? What could be more difficult than watching your child than watching your child slip into retardation via drugs and
seizures? Unhealthy? Compared to what? No science? No need to deal
with that subject again. The medical destiny of each of us and our children is largely up to the patient and his/her family. To think otherwise can be damaging. There is a tendency when we walk into a doctor’s office to want to hand over our problem to the doctor and say, “Here it is, please fix it.” It’s comfortable, it’s easy, and more often than not, it works. Just as we take comfort in deferring to them, many doctors are unwilling to
confide in us that we may have stepped into one of Western medicine’s black holes. There are
many and they are deep, and kids with difficult-to-control seizures are among them. So what does that mean? It means that our medical problems and our
childrens’ medical problems are precisely that -- OURS. At first, that’s a pretty
intimidating and perhaps a seemingly foolish concept, both to us and to some physicians. After all, they went through years of education. They’ve seen countless patients in their practices. And then we walk into their offices with a disease we probably don’t even know how to spell. How presumptuous and perhaps foolish of us, the patients, to ask and then pursue the hard questions, learn the side-effects, get the second opinions, do the research, and participate in the cure -- in short, become proactive. Ironically, the "side-effect" of participating in our medical destinies may not only lead to getting better sooner. It is empowering. Though I would do almost anything to go back and have Charlie not suffer epilepsy, the experience has been empowering. Whether or not responsibility for informing ourselves confirms the information we learn from our physicians, it’s nevertheless empowering. As fate would have it, I am writing this afterword from a hospital bed where I am fighting leukemia. But the bed I am lying in, the treatment I am undergoing and the doctor who is helping me are not arbitrary. Though my diagnosis was shocking and treatment was needed immediately, there was time to find information, interview oncologists and even visit hospitals before setting sail on a course. Mercifully, I found a doctor who is bright, compassionate and believes in informed joint decision-making. We take control of so many lesser issues in our families’ lives -- meals, bedtimes, TV hours -- why not have that same attitude with the most important issue - our families’ health? In the worst case, we have learned something new; in the best case, we have improved either our lives or the lives of our children. There is no downside.'



https://web.archive.org/web/20080123063544/http://www.charliefoundation.org:80/noframes/diet/overview.php

'
'The Ketogenic Diet in Pediatric Epilepsy

Jong M. Rho, M.D.

Key Points
--Ketogenic diet helps control seizures in up to two-thirds of children refractory to anticonvulsant drugs
-- Children with partial seizures may not respond as well to the diet
-- The role of ketone bodies as markers of seizure control is imprecisely defined
-- Their role as direct anticonvulsant agents is also unknown
-- Tests for transporter defects and enzyme deficiencies help screen diet candidates
-- Important clinical questions about the ketogenic diet remain unanswered


Most practicing child neurologists possess a basic understanding of the ketogenic diet---the highfat, low-protein, and low-carbohydrate diet for treating children with epilepsy who do not respond to or cannot tolerate drugs. This diet mimics the biochemical changes associated with starvation and induces, among other changes, production of ketone bodies (mainly beta hydroxybutyrate, and to lesser extent, acetoacetate and acetone), which has been implicated in the mechanisms of seizure control.

Before the historic first announcement of results with the ketogenic diet by the Mayo Clinic [Wilder 1921], bromides and Phenobarbital were the only effective options for antiepileptic therapy. Fasting as a method for controlling epilepsy had been reported sporadically long before this time. However, it was only with such reports in the clinical journals did other
medical centers begin adopting the ketogenic diet as an effective treatment for intractable cases of epilepsy.

Still, the diet remained generally under-utilized, being utilized mainly at institutions such as the Mayo Clinic and Johns Hopkins, until the 1990s when a national television program aired a report on a child whose epilepsy was cured by the ketogenic diet. Later, the Charlie Foundation (named after the young patient) was formed and a television movie recounting Charlie’s success with the ketogenic diet was produced. It also prompted a flood of inquiries to pediatric neurologists and epileptologists about this treatment option.

Even today, however, after a long history of clinical use and the recent surge of professional interest and research, many questions remain unanswered about the ketogenic diet. The purpose of this review is to update neurologists by highlighting key issues and controversies pertaining to this important diet-based therapy for epilepsy. In particular, the review will focus on the potential role of ketone bodies in energy metabolism and in seizure control, the indications and contraindications for the ketogenic diet in pediatrics, and other practical clinical questions involving efficacy, patient selection, monitoring, and side effects.


Diet Overview
The classic ketogenic diet starts with a period of fasting and relative dehydration aimed at achieving ketosis, which is reflected by elevated ketone levels in the urine. There are several variations on this theme (e.g., the medium-chain triglyceride or MCT diet), all based on the principle that one can “force” the organism to use fatty acids and ketones as the main sources of energy, while decreasing the utilization of carbohydrates [Freeman et al, 2000]. This important diet initiation is usually accomplished in a hospital or specialized outpatient setting. An example of the dietary regimen after this introductory phase is listed as follows:

-- Restrict total calories to 75% of the recommended daily allowance, with 90% of the calories coming from fat
--Restrict protein to 1 gm/kg
--Provide a very small amount of carbohydrate
--Restrict fluid intake to 60-70 cc/kg/d
--Supplement this diet with vitamins and minerals

The target for the overall ratio by weight of ketogenic foods (i.e., fats) to anti-ketogenic foods (carbohydrates and proteins) is usually 4:1 or 3:1. Maintaining such a high ketogenic potential usually entails a diet of fatty oods, creams, and special oils. A dietitian or a nurse with special
nutrition training is required to tailor ketogenic diets for children and to help families adhere to exacting strict regimen. Also, before being placed on the diet, the child with intractable epilepsy should always be evaluated within the context of a childhood epilepsy center. Only a thorough evaluation in such a setting will ensure that surgical or pharmacological treatments with potentially greater success rates are not overlooked.

Most treatment centers leave the child on the diet for 2 to 6 months to assess potential efficacy. If the patient is seizure-free, as with anticonvulsant therapy, the therapy continues indefinitely for at least a two-year period. With such success, the patient can be weaned from the diet. There is clinical evidence to suggest that early intervention with the diet may even alter the processes of epileptogenesis and render a permanent cure. However, if a patient is taken off the diet (thus breaking ketosis) and seizures recur, it may be difficult to regain control after reinitiation of the diet due to a persistent of high insulin levels in the face of lowered glucagons. Therefore caution is recommended in prematurely removing patients who have been successfully controlled.



Intermediary Metabolism and Ketone Bodies
Elevated levels of ketone bodies have been strongly associated with seizure control and seizure freedom, and all practicing neurologists employ them as biochemical markers of treatment. However, the ketosis produced by the ketogenic diet may not be the main factor in controlling epileptic seizures in children [Schwartzkroin 1999]. Nevertheless, the clinical goal has historically been to achieve high urine ketone levels, and the importance of this time-honored practice can only be appreciated through an understanding of intermediary metabolism.

When the glycolytic pathway is deprived of glucose, as during starvation or the ketogenic diet, free fatty acids are mobilized as substrates for mitochondrial oxidation (Figure 1). In addition, certain amino acids may be converted to ketoacids that can provide other substrates (e.g., alanine to pyruvate) for Krebs cycle activity. The hepatic microsomal system can also convert fatty acids to dicarboxylic acids (via omega oxidation). These dicarboxylic acids require carnitineesterification for urinary secretion [Sankar & Sotero de Menezes, 1999].

Free fatty acids are not readily available to the neuron itself. However, fatty acids can undergo aseries of conversions and translocations to produce acetate substrates for ketone body production. These ketone bodies are carried across the blood-brain barrier (by a fasting-inducible transporter called the monocarboxylic acid transporter) and into the neuron where they are available as an energy substrate for cerebral metabolism.

Thus, one major physiologic role for ketone bodies is to provide an alternative energy substrate for brain and muscle under conditions of fasting or a high-fat diet. In a classic study of fasting obese volunteers, for example, glucose utilization accounted for only 29% of the brain’s oxygen
consumption while ketones extraction accounted for 52% [Cahill 1966]. Playing another major physiological role, ketone bodies act as the principle source of energy during early postnatal development. Furhter, they are the substrates for the carbon skeleton of lipids that comprise the cell membranes of growing brains and organs. Thus, ketones are involved in both the energy supply and lipid biosynthesis of the embryonic central nervous system (CNS).

But do ketone bodies exert a direct antiepileptic effect? Can they modulate neuronal excitability? Several clinical studies have now shown that diet-induced ketosis (especially at very high concentrations) seems to correlates with the level of seizure control. (The most recent studies will be discussed later.) Also, abrupt loss of seizure control has long been known to occur within hours after ketosis is broken [Huttenlocher, 1976].

Thus the compelling question remains: are ketones directly responsible for anticonvulsant activity? Or are they just an epiphenomenon of some other diet-induced physiological change? These questions have been explored in varied experimental settings.
&Mac183; ß One recent animal study, for example, showed that ketone bodies do not directly alter the excitatory or inhibitory hippocampal synaptic transmission. [Thio 2000] Neither beta-hydroxybutyrate nor acetoacetate affected whole cell currents evoked by glutamate, kainite, or gamma aminobutyric acid (GABA) in cultured hippocampal neurons. The ketone bodies also failed to prevent spontaneous epileptiform activity in the hippocampal-enterorhinal cortex slide seizure model.
&Mac183; Results from our laboratory in cultured mouse neocortical neurons were similar, with no effects of the ketone bodies on the classic neuronal targets of anticonvulsants. Investigators should also be aware that beta-hydroxybutyrate is a stereoisomer, with the D-isomer being the biologically relevant species. The non-physiologic L-isomer possesses anticonvulsant activity both in vivo and in vitro, and is due to the presence of a contaminant, dibenzylamine.
&Mac183; Similarities in the chemical structures of beta-hydroxybutyrate and GABA have led to speculation about GABAergic inhibition induced by the ketogenic diet. Results from studies are conflicting, with one showing no changes in whole brain GABA [Al-Mudallal 1996] and another demonstrating that ketonescan increase GABA in synaptosomes. [Erecinska 1996].
&Mac183; Finally, magnetic resonance spectrophotometric techniques have shown elevated levels of cerebral ketones in patients who are successfully controlled by the ketogenic diet [Pan et al., 1999].

Overall, the experimental evidence supporting a direct link between ketone and seizures is far from convincing. Indeed, as with the underlying causes of the seizures themselves, the ameliorating actions of the ketogenic diet may be multiple, with a host of diet-influenced metabolic changes acting in concert to decrease membrane excitability.

But even as research continues, the clinical connection between peripheral ketone levels and seizure control still impels clinicians to confront more practical questions. For example, what assay method should be employed to monitor diet efficacy? Urine dipsticks are commonly used for this purpose but these measure acetoacetate, the less prominent ketone body. Which ketone body actually correlates best with seizure control is unknown. If beta-hydroxybutyrate ketone is actually the preferred marker, a new reflectance meter (Keto-Site™, GDS Diagnostics) will assay the D-isomer from a small drop of blood. But then, what is the “therapeutic concentration”
for either of these ketones? And what does the peripheral level predict about the brain level?

Clearly, many questions remain about the physiological relevance and the practical utility of monitoring ketone bodies in the ketogenic diet.


Special Indications and Contraindications
Several specific inborn errors of metabolism can upset mitochondrial function and lead to dysfunctional glycolysis. Children with these special conditions may be strong candidates for the ketogenic diet, which will provide an important alternative energy source capable of crossing the blood-brain barrier (BBB) and sustaining cerebral energy metabolism.

The best example of such a condition is the family of glucose transporter defects (e.g., GLUT-1 deficiency) where glucose cannot penetrate the BBB [DeVivo 1991]. Two other conditions with less clear indications for special diet are pyruvate dehydrogenase complex deficiency where acetyl CoA production is blocked [Wexler 1997] and glycolysis-upsetting phosphofrucokinase deficiency [Swoboda 1997]. The benefit of the ketogenic diet is even less certain in mitochondrial cytopathies due to Complex I deficiency, which presents in infancy with hypoketogenic hypoglycemia and hepatomegaly [Sankar & Sotero de Menezes, 1999].

_______________________________________________________________________
Insight“In difficult-to-control seizures in infants, especially myoclonic seizures, it’s important to consider an early look at glucose in the spinal fluid even if the child is afebrile. With glucose transporter defects, the ketogenic diet is the treatment of choice.”
Dr. Riviello
_______________________________________________________________________

Most inborn errors of metabolism involving mitochondrial transport of fatty acid oxidation are absolute contraindications for the ketogenic diet. These include, for example, deficiencies in carnitine (primary or secondary), carnitine palmitoyltransferase I or II, and translocase. The most common fatty acid disorder to be vigilant for is the medium-chain acyl dehydrogenase deficiency (MCAD). Other such deficiencies include those of long-chain acyl dehydrogenase, short-chain acetyl CoA dehydrogenase, long-chain 3-hydroxyacyl-CoA, and medium-chain 3-hydroxyacyl-CoA.

Clues to an inborn error of metabolism include developmental delay, hypotonia, exercise intolerance, and easy fatigability. In children with these presenting symptoms, several tests can determine if the child is suitable for the ketogenic diet. The recommended biochemical screening tests (in addition to the routine laboratory studies such as liver function tests, complete blood count, etc.) are for urine organic acids, serum amino acids, and serum lactate and pyruvate. As implied in Figure 1, findings of highly elevated dicarboxylic acids in the urine signal a problem with the normal pathway of intermediary metabolism (either mitochondrial cytopathy or a fatty acid oxidation defect) and this warrants further investigation.


Clinical Question
The ketogenic diet is highly effective in some children, but efficacy rates have varied depending on the study. Results from large prospective multicenter trials using either the classic Hopkins diet or the modified medium chain triglyceride (MCT) oil-diet are listed in Table 1. In general, more recent studies have reported lower rates of seizure control, probably due to better tracking of drop-outs (i.e., intention-to-treat analysis) and longer follow-up periods. Overall, about one-third of children come close to seizure freedom on the ketogenic diet, one third have reductions in seizure frequency, and one third do not respond. In recent prospective, multicenter studies, only 10% actually become seizure-free [Vining 1998; Freeman 1998].

Despite generally high efficacy rates in these children who are unresponsive to drugs, many questions about the ketogenic diet require further study. Determining which seizure types respond best to the diet, for example, has been a subject of debate for decades. The early controversy centered on cryptogenic versus idiopathic efficacy [Keith 1963, Livingston 1972]. And more recently, despite some reports of efficacy in both partial and generalized seizures [Schwartz 1989, Freeman 1998] many patient type- for example, those with partial seizures arising from temporal lobe pathology-still appear relatively resistant to the diet’s effects. In fact, patients with partial seizures have been excluded from most studies assessing the clinical efficacy of the ketogenic diet.

Other remaining points of controversy include the benefits of the classic diet versus the modified MCT oil diet, the potential of vagal nerve stimulation as a therapeutic alternative in these drug refractory patients, the long-term developmental effects of restricted protein and calories, and the effect of age on efficacy. On this last point, note that the diet has historically been considered more effective in infants and children because ketone extraction from periphery to brain is more efficient in the developing brain. The clinical data with the ketogenic diet in the adults is sparse, with approximately half the patients responding with greater than 50 % seizure reduction [Sirven et al., 1999].

The potential adverse effects of the ketogenic diet are well known (Table 2). In recent years, the clinical literature has focused on nephrolithiasis, growth retardation, and the potential for cardiac disease. Some of the acute toxic effects can be serious and careful monitoring is required.

Because many children with intractable epilepsy are on valproic acid, the special issue of potential exacerbation of drug side effects by the diet becomes another key issue. In particular, because carnitine deficiency is well documented with valproic acid use, supplementation is recommended in documented cases of deficiency (e.g., plasma free carnitine < 20 _mol/L after the first week of life or an esterifed to free ratio of > 0.4).

The ketogenic diet also increases the risk of nephrolithiasis, a risk that may increase in patients taking carbonic anhydrase inhibitors such as acetazolamide or, potentially, with newer broad-spectrum anticonvulsants that act (in part) at this same enzyme (e.g., topiramate and zonisamide). Preliminary experience indicates that children can be treated safely with such agents combined with the ketogenic diet.

In summary, although its mechanism of seizure control is imprecisely defined and severalpractical details of therapy (e.g., patient selection) require further study, the ketogenic dietremains a valuable option for therapy in the most drug-resistant cases of pediatric epilepsy. Before initiating a trial of the ketogenic diet, the clinician must ensure that the patient has had adequate trials of at least 2-3 anticonvulsants, and has been carefully considered for potential epilepsy surgery or vagus nerve stimulation. A thorough diagnostic metabolic work-up and a frank evaluation of the family’s potential to comply with the diet are also mandatory. In carefully selected patients without other options, the ketogenic diet can provide major benefits, both in terms of seizure control and quality of life.

Q&A
Q1 Why not just use the Atkins diet? Isn’t that ketogenic?
Dr. Rho: Many different diets are variations on the ketogenic theme but we
simply don’t have the clinical data to say which works best.
Dr. Morton: We also need to counsel patients who have initiated this diet on
their own. Just because the do-it-yourself Atkins book is available at Barnes and Noble and it’s talked about in a keto chat room doesn’t make it safe. I had one patient who became hypokalemic on the diet.

Q2 Is he vagal nerve stimulator replacing the ketogenic diet as an option for children who are not traditional surgical candidates?
Dr. Rho: To some degree, that was our experience at the University of Washington in Seattle. The overall use of the ketogenic diet at several major centers has fallen somewhat in the past few years.
Dr. Bourgeois: It depends on the seizure type. At Children’s Hospital in Boston we still prefer the ketogenic diet for those with Lennox-Gastaut and similar epilepsies. The VNS might be considered for those few children with partial seizures who are not surgical candidates, but overall our use of the ketogenic diet has stayed about the same.
Q3 What is the role of the family in success of the ketogenic diet?
Dr. Rho: The diet involves an exacting formulation and regimen and the family and social structure of the patient is critical to its success. If the family cannot help maintain complete compliance, ketosis cannot be achieved. Even small lapses such as not eating the whole meal (to maintain the proper ratio) or eating substances that contain sugar (whether a candy bar or even certain anticonvulsants) can undermine the diet. Family support is critical in maintaining a child on this diet.
Table 1. Clinical Efficacy of the Ketogenic Diet
Study Diet Seizure-Free Seizures_ Follow-up
By&Mac179; 90%

Livingston 1954 Classic 43% 3 months
(n= 304) (“controlled”)

Schwartz 1989 Classic 46% 3 months
(n=59) MCT 37% 3 months
Mod MCT 41% 3 months

Kinsman 1992 Classic 29% 38% 31 months
(n=58) (50-99%)

Swink 1996 Classic 22% 22% 12 months
(n=22)

Freeman 1998 Classic 7% 20% 12 months
(n= 150, intent to treat)

Vining 1998 Classic 10% 20% 12 months
(n=51, intent to treat)


MCT: Medium chain triglyceride



Table 2. Side Effects of the Ketogenic Diet
Possible long-term effects of high fats (cholesterol, triglycerides)
Growth retardation due to protein deficiency
Vitamin and mineral deficiencies
Constipation
Kidney stones
Elevated uric acid production
Impaired immune defenses (possibly related to neutrophils)
Metabolic acidosis
Liver failure



Figure 1. Taking the Alternative Route to Cerebral Energy Generation:
Metabolic Shifting with Ketogenic Diet'




Fall 2003
Volume 16, Number 2

A Talk with John Freeman:

Tending the Flame. 
Freeman's route with the ketogenic diet calls to mind Gandhi's comment: First they ignore you; then they laugh at you; then they fight you; then you win. 


Whipping cream. Bacon. A lot of food that feels like sin is in the ketogenic diet, an approach to intractable epilepsy that was once embraced, then scoffed at. Now it's newly accepted again, thanks in no small part to efforts by pediatric neurologist John Freeman, M.D., and a dedicated team.

In the 1920s, when bromides and phenobarbital led approaches to epilepsy, the alternative-a high-fat, very low-carbohydrate and protein regimen-gave about a third of child patients excellent to complete control of their seizures. The rest on "the ketogenic" had at least 50 percent control or better. In part because the diet was so unusual-it mimics seizure-quelling metabolic changes that come, oddly enough, after days of fasting-and in part because nobody had a clue to how it worked, the ketogenic route seemed magical. 

"All that, for the most part, hasn't changed," says Freeman. Today, parents of the nearly 500 children he and his team have treated still shake their heads that such an approach can work. "And what we don't know about the diet still exceeds what we do,"Freeman says. What's different, however, is that he and colleagues Patti Vining, M.D., and Eric Kossoff, M.D., have worn down naysayers-and there've been some-with sound research. 

They've shown, for example, that diet advantages extend to teenagers, that children's growth is only mildly slowed and that side effects like kidney stones are manageable. They've correlated blood levels of one ketone body-a metabolic byproduct-with efficacy in stopping seizures and have published protocols on keeping patients on the dietary straight and narrow.

Q. There's no denying the obvious about the ketogenic diet: it's loaded with fat.
A. That's true. The version we use is 90 percent fat, with 4 to 8 grams of carbohydrate and 1 gram per kilogram weight of protein daily. Most people's first reaction is "yuk." Yes, patients drink heavy cream. But the diet's palatable: Mushroom omelets with bacon. Broccoli with cheese. There's variety. 

Q. And you certainly need the fat...
A. … because it gives the desired effect. Normally, fat is burned to carbon dioxide and water. But that's in the presence of carbohydrate. Without the Mars bars, fat's incompletely oxidized. Then blood levels of ketones-specifically beta-hydroxybutyric acid (HBA) and acetone-begin to rise. We think ketones are largely responsible for the diet's effects. One of our studies shows seizure rates drop as levels of HBA rise.

Q. How would anyone think up such a diet for epilepsy? 
A. What you're doing is mimicking the effect of starvation. In the 1920s, people discovered that fasting 10 to 20 days might control seizures for weeks or even years. The fellow who developed the ketogenic diet-not me-knew that rigorous fasting prompts ketosis. In 1922, after trying the diet on patients, he saw their seizures decrease rapidly.

Q. But then the diet went out of favor?
A. Yes. In 1938, Houston Merritt discovered Dilantin, a wonderful anticonvulsant but a setback to our understanding the ketogenic diet and epilepsy in general. It's easier to take a pill than to fast for 18 to 25 days and stick to a diet. So most people switched. Only a few places like Hopkins continued the diet for small numbers of patients.

Q. Yet, there's been a resurgence of interest?
A. There has. In 1993, a Hollywood producer, Jim Abrahams, called me. His young son Charlie had suffered thousands of seizures. He'd been through all the medications, had seen five different pediatric neurologists, had had a fruitless surgery and still lived with hundreds of seizures a day. Then Jim came across a chapter on the ketogenic diet in a library book. He called us; we put Charlie on the diet. The boy's seizures were completely controlled. 

Jim was outraged that nobody'd informed him of the diet! So he began to publicize it. Then came The Deluge. After Charlie's story appeared on "Dateline," we got 5,000 phone calls. Now, years later, interest is still steady.

There've always been patients with uncontrollable seizures. Their desperation is real and the diet offers a valid option.

Q. How's the diet sit with most clinicians?
A. When we started publishing studies in 1996, nobody believed us. When we held a press conference after our first multicenter trial, the president of the American Epilepsy Society stood up and said, "it's never been studied in a blinded fashion." That really stuck in my craw. So we've steadily ticked off studies, all of which support the diet's efficacy and safety when done properly. And we've just finished the double-blind, crossover study and are analyzing data.

Many epileptologists don't use the diet. They believe it works-our studies show-but they lack staff. The secret to the ketogenic diet is the dietitian. There's a lot of interaction with the dietitian, a lot of education because the diet's not easy. Actually, it takes a team, and we have an excellent one.

Q. Why don't you see adults on the diet?
A. A good question. As far as we know, no biology lies behind its not working for them. At the least, it might help adults leave or lower medications. But I'm a pediatric neurologist. 

Q. You say the diet may have other uses?
A. Possibly. We know ketones preserve heart muscle up to a point after heart attack, probably because an oxygen and glucose-starved heart can use them as an alternate energy source. Would a keto diet be helpful? What about strokes? The brain can metabolize ketones. Would it help stroke victims to go on a short keto diet?

Q. And the future for epilepsy patients?
A. Sooner or later, we'll understand how the diet works. Why, for example, does the diet control seizures in some children who've failed six drugs-not only while they're on it, but apparently forever after they've stopped?

Something has fundamentally changed epilepsy's "on" switch. We hope the diet will lead us to that switch, and to a therapy that doesn't involve whipping cream.


https://www.charliefoundation.org/blog/entry/mrs-kelly


Mrs. Kelly


Mrs. Kelly
Mrs. Kelly
Ironically, though the Ketogenic Diet is underutilized due largely to a dearth of keto dietitians, the argument could well be made that none of us would be reading this blog, and perhaps today the diet itself may have faded into extinction, were it not for one  particular dietitian, Millicent Kelly RD.  Along with Dr. John Freeman and Dr. Samuel Livingston, she became the dietitian at Johns Hopkins that quietly put so many hundreds of children on the ketogenic diet and kept the diet afloat while fighting a near perfect Western medicine storm of modern drugs, their simplicity of use, and their enormous profit margins.
Mrs. Kelly, as her patients came to call her, enrolled at Johns Hopkins after college graduation in 1948 to take a one-year course as a student dietitian.  She formally retired in 1999. She learned the diet from Dr. Samuel Livingston, a Johns Hopkins pediatrician and a passionate advocate for the diet. In 1953 he published that of 304 patents he had put on the diet, 43% had complete seizure control and another 34% were markedly improved.  (As a measure of how times have changed, Livingston not only would make follow-up house calls on his keto patients, he would frequently take a week at a time and travel from Baltimore to Texas, Florida, or Wyoming to see how they were doing).  It was in this positive environment that Mrs. Kelly learned and then helped perfect the diet, one child at a time. 
Two decades later, in 1973, though the keto dietary staff at Hopkins had shrunk to Mrs. Kelly and just a few other dietitians, Livingston wrote, “Since 1958 we have treated an additional 575 patients with the ketogenic diet regimen and the results with regard to seizure control were essentially the same as those reported earlier.”  Yet the patient lists dwindled as new, easily prescribed drugs came along and overwhelmed the work intensive ketogenic diet.
It was about this time that Livingston retired and handed over the reins of the ketogenic diet program to John Freeman who, equally impressed with the diet’s success and challenged by the absence of medical acceptance in the face of modern drugs, found a way to keep the diet afloat--found a way within the Hopkins machinations to keep Mrs. Kelly helping fifteen to twenty sick kids per year stop having seizures with a diet and her gentle tenacity. 
Decades passed.  More new drugs were introduced.  Other ketogenic diet centers began to fall by the wayside.  One by one, the dietitians dropped out of the keto program leaving Dr. Freeman and Mrs. Kelly, along with Diana Pillas coordinator-counselor at Hopkins Pediatric Epilepsy Center, the lone slender threads that kept the ketogenic diet helping kids at Hopkins.  By 1990, contract food services took over the keto nutrition at Hopkins complicating her work even more acutely.   Later that year when Mrs. Kelly was demoted within the nutrition department, she went to Dr. Freeman to announce her retirement.  Freeman, whose rebellious, persistent spirit is loved by all who know him, fully understood Mrs. Kelly’s importance to the very existence of the diet, and would have none of it.  He found a way to keep her on board as Pediatric Dietary Consultant to Pediatric Neurology.  Mercifully, she stayed. 
In 1994 the ketogenic diet dramatically circumvented traditional medical information distribution routes, and awareness of its success went straight to millions of families through mainstream media focus.  Public demand fueled an enormous resurgence of interest in the diet within the scientific and medical communities.  It began to achieve a new foothold in epilepsy treatment and has begun to restore its rightful focus within the neurology community.  Today, with over 200 ketogenic diet centers world wide, it is once again becoming a priority in the treatment of children and adults with difficult to control seizures, other neurological disorders, and certain cancers.
But one has to wonder where this story might have ended were it not for the Livingston/Kelly/ Freeman connection.  What might have happened if Mrs. Kelly had simply gone away?  So I asked her recently what kept her going through all those years of hard work, little pay, and even less recognition.  “I thought it was my job,” she said.  “I met some of the nicest people.  Some of those mothers and fathers and families--what they had to endure.  If I could do something, I had to.”  
Jim Abrahams
The Charlie Foundation

The Ketogenic Diet: One Decade Later

John M. FreemanEric H. KossoffAdam L. Hartman

Abstract


The ketogenic diet, a high fat, adequate protein, low carbohydrate diet, has, during the past decade, had a resurgence of interest for the treatment of difficult-to-control seizures in children. This review traces its history, reviews its uses and side effects, and discusses possible alternatives and the diet’s possible mechanisms of action. Finally, this review looks toward possible future uses of the ketogenic diet for conditions other than epilepsy.'


https://www.charliefoundation.org/blog/entry/connie


Connie


Connie
*Photo at left is of Charlie Abrahams and Tim Indermittee - 2 seizure free kids, circa 1996.
When Charlie started the Ketogenic Diet and his seizures went away so dramatically at the end of 1993, I asked Dr. Freeman from Johns Hopkins three questions.
1) Why did we have to find the diet on our own?
2) Why didn't any of the pediatric neurologists we saw tell us about the diet?
3) Why, even when we learned of the diet as a treatment option, did they try to talk us out of it?
Although I didn't fully grasp the dark implications of his answer at the time, here's what Dr. Freeman said, "The Ketogenic Diet will never become popular again if you try raise awareness through traditional means of medical communication (meetings, papers, etc.).  If you want to help restore the diet's rightful place as an early treatment option for children with seizures you need to circumvent the medical community and go straight to the public with this information." 
Dateline NBC found out about Charlie as we were making our introductory video to the ketogenic diet and came to film his story.
In anticipation of what Dr. Freeman called "the deluge" from the huge public demand that would occur when the diet was revealed to the world on a national level, he and the Charlie Foundation held a conference at which directors from seven other epilepsy centers from around the country came to Hopkins with their dietitians to learn about the diet.  Nonetheless, the public demand from the broadcast caught the medical community largely flat footed.  Dr. Freeman said that his clinic alone got over 5,000 calls during the week following the broadcast.
I also tried to read as many of the thousands of letters and requests for information we received at The Charlie Foundation.  They were incredible: grateful for hope, angry about lost years, heartbroken over potential unnecessarily damaged lives.  
But one letter stood out as a new direction to reach the public.  It was dated 10/27/94 and was kind of a stream of consciousness from Connie Indermittee, a Chicago area mom who had seen Dateline the previous night.  The program had triggered memories of her experiences and feelings from the mid 1970's when she found the ketogenic diet for her son, Tim.  Though in many details it was uniquely dramatic, in essence it was the story of all the families who have had to battle through epilepsy's costs, stigma, medical resistance, and ineffective and debilitating drug treatments to find diet therapy.
I read her letter and made three phone calls.
The first was to Connie to ask if I could come visit.
The second was to Dr. Freeman to share the story.  (Tim had started the diet at Hopkins also).
The third was to Meryl Streep, who had helped us with the introductory video,  to ask, "What  do you think?
Please take the time to read the letter below from Connie Indermittee which ultimately provided the plot for the movie "First Do No Harm", written and directed by Jim Abrahams. We wanted to share this very special letter beacuse Connie's story represents the story of EVERYONE who at one point, may of felt helpless as a parent to find a treatment that works for their child or loved one.  Thank you Connie and the entire Indermittee family for continuing to inspire everyone to never give up.

See transcribed letter below handwritten letter.
 connie 1
 connie 2
 connie 3
 connie 4
connie 5

 connie 6

"Dear Sir,
In April 1978 my 3 year old son had 1 gran mal seizure. We took him to the hospital and all the tests proved nothing. In the next 7 months, we took him to 6 other hospitals, 21 doctors, and 38 drugs. He had between 150 and 200 seizures a DAY. He spent the last 2 1/2 months at Pres-St. Lukes in Chic (Chicago) in intensive care. He was scheduled for exploratory brain surgery. I was almost praying Tom would die instead of living the rest of his life as a grossly retarded person with this problem.
I must stop for a minute and tell you, as I write this chills run down my spine. This was a nightmare that you relived for me on Dateline. I was going crazy trying to (self) cure my son. I went to the U of I Library and read - for weeks - from the time they opened to closing.
I got a copy of Sam Livingston's book. I read the Ketogenic Diet. I called Baltimore, They told me to come right away -
I tried to take Tim out of the hospital. I realized I'd LOST the custody of him. They would not let me transfer him from Pres-St. Lukes to John Hopkins. I stole him from the hospital. I had the help of 2 others to pull it off. He was on Valium IV 24 hour plus 8 other drugs.
I knew he could die. They knew he could die. He was seizing every 1/2 to 3/4 hour.
We had an ambulance come in the middle of the night. (at shift change) Took him to a commercial flight to Baltimore. Pulled the IV so we could board- wasn’t sure if he'd live to see Baltimore. We arrived - went to Livingston clinic - went to J.H. Hos. - 3 days starvation - went on the Ketogenic diet. A pure miracle -.
Tim is 19. He has not seized since that trip to Baltimore. He is a smart beautiful boy. He attended 1 year of college. He's a lucky kid, like yours.
Since, I tried to tell people about this method of treatment. The doctors here in the Midwest would not even consider its use. They would not admit that this is the cure for children with multi seizure.
If I had to do this all over again - I don’t know if I could. It financially devastated us. My husband lost his job. My other 2 children were virtually abandoned by my husband and I. We begged Fed Land Bank not to take the farm from us. The neighbors helped by taking the other kids, filling the freezer with food and most of all their prayers.
I stayed at Notre Dame Convent in Baltimore, as I had not any money for a motel. I stayed in the cloister as that was the only place there was to stay. All the sisters prayed a miracle would happen. It did. The Ketogenic diet saved my son.
The hospital taught me how to administer the diet. They were great. they wrote all the costs off as they knew we were totally financially broke.
For 2 years I followed the diet with Tim. We found that to be very hard, but we did it.
I have shopping bags full of medical records that would blow your mind showing the various treatments. I had doctors telling me they exhausted every treatment known, so just take him home and live with him seizuring - with no hope for any future for Tim.
As I write this, my heart is skipping. I remember like yesterday the ordeal we went through. I wish that NO ONE, ever. I tried so hard to tell my story to Readers Digest, local and larger news - media, and they weren't interested. Think how many children could have been saved.
Please write me. I may be of help to you and the awareness of this treatment. Keep it in mind that no doctor ever - in Chicago- had ever "tried" this diet. I begged them. They would not. When the tribune writer realized that I was bashing some of the most thought of doctors in the Midwest - they canned the whole story. To this day the pediatrician who first took care of Tim does not believe that is what cured Tim's seizure problem.
I almost hate all doctors now. They almost killed my son.
By the way - how we got to fly to Baltimore - My neighbor was a doctor and a pilot. He arranged the flight - the ambulance - the escape from Pres. St. Luke's. He could have been fired from his airline and lost his license to practice medicine. The risk he took was huge - the results were worth it.
Again please let me know you received this. I now realize someone else went thru the ordeal of this size.
Please excuse this poorly written letter. I shake when I think of those days - I forgot to slow down while writing - but it's readable, so I'm sending it. I kept a daily journal during those days and you relived them last night.
Please send me the video. thxs-"
Connie Indermittee


Wednesday, December 06, 2017

Cutting re Laura Hillenbrand and CFS

https://well.blogs.nytimes.com/2011/02/04/an-author-escapes-from-chronic-fatigue-syndrome/

An Author Escapes From Chronic Fatigue Syndrome


Laura Hillenbrand, the best-selling author of “Seabiscuit: An American Legend,” is known for her exuberant storytelling and dynamic characters. Her newest book, “Unbroken: A World War II Story of Survival, Resilience and Redemption,” is a riveting tale of the life of an athlete and war hero, Louis Zamperini.

Ms. Hillenbrand’s ability to transport her readers to another time and place is all the more remarkable in light of the fact that she is largely homebound, debilitated by chronic fatigue syndrome, or C.F.S.
The illness, a devastating and little understood disorder, is characterized by overwhelming fatigue and various nonspecific symptoms like muscle pain, memory problems, sore throat, swollen lymph nodes, achy joints and unrefreshing sleep. I recently spoke with Ms. Hillenbrand about her latest book and why she is speaking out about the challenges of life with C.F.S. Here’s our conversation.
Q.
Why have you started talking about your illness?
A.
I had never been public about my illness at all before “Seabiscuit.” I didn’t want to talk about it very much because I had the experience of being dismissed and ridiculed. People don’t understand this illness, and the name is so misleading. I realized I had this opportunity because I was going to be getting press attention for the book. I’m going to talk about it because I can. Maybe that will save the next person from going through what I did.
Q.
Do you think it’s hard for people to understand how debilitating chronic fatigue can be?
A.
This is why I talk about it. You can’t look at me and say I’m lazy or that this is someone who wants to avoid working. The average person who has this disease, before they got it, we were not lazy people; it’s very typical that people were Type A and hard, hard workers. I was that kind of person. I was working my tail off in college and loving it. It’s exasperating because of the name, which is condescending and so grossly misleading. Fatigue is what we experience, but it is what a match is to an atomic bomb.
This disease leaves people bedridden. I’ve gone through phases where I couldn’t roll over in bed. I couldn’t speak. To have it called “fatigue” is a gross misnomer. Most people, when they hear the disease name, it’s all they know about it. It sounds so mild. When I first was sick, for the first 10 years or so, I was dismissed. I was ridiculed and told I was lazy. It was a joke.
Q.
When did you learn you had chronic fatigue syndrome?
A.
I got it when I was 19, and I was diagnosed at 20 by the head of infectious disease at Johns Hopkins. It was the most hellish year of my life. I went from doctor to doctor. I got very thin and lost 22 pounds in a month. One doctor thought I was anorexic and lectured me about it. After my appointment he followed me to the bathroom and put his ear to the door. When my doctor at Johns Hopkins finally said, “You have a real disease,” that was an important moment for me.
Q.
What were your first symptoms?
A.
As it does in most people, it had a very sudden onset. I was an athlete and had always been healthy. I was riding in a car on my way back from spring break my sophomore year of college and felt very nauseated. I guessed it was food poisoning. I woke up a few days later, and I literally could not sit up, I was so weak. It hit me that fast. I had to drop out of school because I couldn’t make the walk to the classes.
Q.
What happened once you left school?
A.
I was bedridden the first two years. I was having fever all the time and huge lymph nodes; the reddest, rawest, terrible sore throat; typical sweats and chills like the flu, but it didn’t go away, month after month. I had the most extreme exhaustion and balance problems, strange cognitive things, trouble concentrating. I couldn’t read analog clocks anymore. I’d try to say one word and a different word would come up. I had brain fog that was terrible in 1987 and 1988, and then it started to slowly get better.
I did better until 1991, when I tried to take a road trip to Saratoga. I had a catastrophic C.F.S. crash, went into shock, and went back down to the bottom to worse than ever. Then vertigo started, and ever since the room appears to be moving around me. I feel like I’m moving all the time.
Q.
How are you now?
A.
I’m housebound now. I had a relapse while I was working on the book in 2007. I got weaker than I’ve ever been. I’ve been too weak to leave the house for two years. I only leave the house about once a month. I’m just not very strong. A lot of days I don’t get down the stairs. It’s a slow process to recovery. The book publicity is quite difficult for me. I’m not able to do that much of it. It’s taking a whole lot out of me.
Q.
It’s hard for me to imagine how you could have done the research and writing for two books during this time. How did you do it?
A.
It’s a trade-off for me. While it’s really hard to do, at the same time, I’m escaping my body, which I really want to do. I’m living someone else’s life. I get very intensely into the story, into the interviews and the research. I’m experiencing things along with my subjects. I have a freedom I don’t have in my physical life.
Writing is a godsend to me that way. Without it I wouldn’t have anything. I am completely still almost all the time. A lot of time I don’t leave the upstairs. What I have is the story I’m working on. It’s a wonderful thing for me to get out of my body for a while.
Q.
Do you think having C.F.S. influences your writing?
A.
Because my life is so silent and so still, I think I’m able to get deeper into what I’m working on. My mind is willing to get out of here and go into there. It becomes such an intense experience.
Q.
Did you always want to be a writer?
A.
At the time I got sick, I wanted to be a history professor. I was 8 years old when I went across the street from my house to a fair, and they always had a used book sale. For a quarter I bought a book called “Come On Seabiscuit.” I loved that book. It stayed with me all those years. I was sick and housebound and looking for something I could write about. I wrote an article. I was partway through it and realized there was a huge untold story.
Q.
How did you do the reporting for the book?
A.
Lots and lots of interviews, at least a hundred, and going through newspaper archives. The family of Seabiscuit’s owner sent me 30 enormous leather scrapbooks. I bought so many things on eBay — vintage things, magazines. I did many interviews with very, very old men.
Q.
Who helps you manage your life?
A.
I’m married. I have a wonderful husband. The house is all set up for me. There is a refrigerator upstairs. My desk has everything I need. Toaster, utensil and bowls, teapot — everything I need. I got married in 2006. We’ve been together since before I got sick. He’s my college sweetheart. We waited to get married until I got reasonably well. I was too sick to go to the reception. I was just at the wedding for a few minutes. He has been through this with me. Some couples it would drive apart; it has drawn us together. We have a deep understanding. He doesn’t see me as a sick person. He sees me as everything else I am. It’s a really wonderful relationship. We had to learn how to do it. It’s not easy at all to be a couple with a disease.
Q.
Why did you decide to write about Louis Zamperini?
A.
Seabiscuit led me to him. My subject was one of the greatest runners in the world in the 1930s, likely to break the four-minute mile. Seabiscuit was famous at the same time. All the newspapers that covered Seabiscuit also covered Louis. I kept reading about him. When I got done with Seabiscuit, I wrote him a letter and called him, and he told me his life story. I had to write this book.
It’s the most amazing survival story. Louis was an Olympic runner who hung up his shoes and became a bombardier. He crashed in the Pacific and floated on a raft for 47 days. Sharks jumped on board to pull him off. He was attacked by a Japanese bomber. He nearly starved to death. He went through a typhoon and was captured. His captors experimented on him, enslaved him, and he was a prisoner for two years. The things that happened to him, and his defiance — it’s an amazing story.
Q.
It sounds like on some level you could relate to him.
A.
I think because of what I’m dealing with, I’m really interested in people who become trapped in extremity and have to rely on their character to pull them out of it. I’m fascinated by the struggle, and the attributes that enable people to survive these things. I want to look to them for inspiration. I think that’s why I’m drawn to it.
Louis has told me he felt I was someone who was easy to open up to because he knows I’ve suffered. With someone else, I think he might have been a little more taciturn. But he felt, “She gets it. She’s been to this place herself.”
Having to go all the way to the bottom of yourself to find the resources to survive: this is something I understand well. I understand desperation. It’s an emotion I have dealt with a thousand times in the last 24 years. You feel like you don’t know where you’re going to get the strength to go on. We’ve been to the same place in different circumstances. I’m not comparing myself to a prisoner of war, but there are common emotions that enable me to identify with him.
Q.
Do you think your writing would be different if you didn’t have this illness?
A.
I don’t remember what it’s like to feel well. I’m 43. I was 19 when I got sick. It’s a lifetime ago. It’s hard for me to imagine what I would have been as a writer without the history I have now. We’re all sitting in our particular circumstances and writing from that place.
Q.
Your personal story is so compelling. Have you thought about writing something autobiographical?
A.
My husband wants me to. I just don’t know that I want to do that. I have to spend so much time being vigilant on my body and worrying about my body and suffering. So much of my own autobiography would be about my health, and I don’t know if I want to spend my professional life thinking about that. I write to escape my circumstances.
Body willing, and if I can find a subject that compels me, I’ll keep writing. It’s a great way to touch the world, because I’m not in this world. I went out recently to the CVS drugstore for the first time, and they had these new checkout things with no person at the checkout counter. I was baffled by this. Writing is my way of communicating with the world, and I don’t have any other way to do it, so I want to keep doing it.

Monday, December 04, 2017

Cutting from Huffpost re crisis in Yemen



http://www.huffingtonpost.co.uk/entry/im-an-aid-worker-in-sanaa-and-no-one-is-safe_uk_5a256717e4b0a02abe929e14?5ju&utm_hp_ref=uk-homepage


I'm An Aid Worker In Sana'a And No One Is Safe

This violence is completely paralysing humanitarian operations

 04/12/2017 15:31 GMT

Suze van MeegenProtection and advocacy adviser with the Norwegian Refugee Council

MOHAMED AL-SAYAGHI / REUTERS
No one is safe in Sana’a at the moment. I can hear heavy shelling outside now and know it is too imprecise and too pervasive to guarantee that any of us are safe. Over the past two days, the capital has endured relentless bouts of intensive gunfire and artillery shelling from all sides— bullets and shelling from Saleh loyalists and Ansar Allah fighters, airstrikes from the Saudi-led coalition. The aerial bombardment continued last night, intensifying further today with more attacks on the airport.
I spoke to a colleague who is trapped, his house between two checkpoints and surrounded by snipers. He and his family are sheltering in their basement, without any electricity, listening to tanks roll by outside. Yemenis have few protections against the sort of violence happening now – and that includes both the bombardments and the more insidious kind that is depriving them of access to food and healthcare.
As with all international aid agencies, our operations are at a standstill. Our Yemeni staff have all been accounted for, though some are in heavily impacted areas, reporting heavy artillery moving immediately outside and snipers on neighbouring rooftops. Most report sheltering in their home basements, but some are now without any electricity.
We have been facing enormous challenges reaching the overwhelming number of people who need assistance to stay alive through the collapse of Yemen’s basic civil services. We faced enormous challenges trying to prevent people from dying of cholera while authorities in Yemen made access to them difficult. The ongoing blockade of commercial imports through Hodeida Port is beyond challenging and will inevitably result in thousands of preventable deaths. But this violence is completely paralysing humanitarian operations. We cannot move from our houses. Sana’a is in hibernation and with it, so is any chance of reaching people with food, water, healthcare or education.
- ADVERTISEMENT -
KHALED ABDULLAH / REUTERS
Roads into Sana’a are blocked, checkpoints are tense and the airport is unreachable due to heavy fighting. The UN aid flights to Sana’a – the only way of getting in and out of the capital – were denied clearance by the Saudi-led coalition, but conditions are in any case currently too tense to enable movement, and airport damage now needs to be assessed.
As international humanitarian workers, we have privileges and protections that leave us as well-equipped as possible to withstand violence of this kind, but our national colleagues may not. The direct and indirect impact of this violence on civilian populations is inestimable. The current violence will bring a whole nation to its knees - on top of almost 1000 days of conflict, and an ongoing blockade that is preventing the delivery of commercial food and fuel through the county’s main port. In just a few days, the fighting has killed and injured civilians, including children. There will be hundreds of casualties – thousands if this is allowed to go on. Facilities have been closed and some medical personnel forced to flee their posts for safety, leaving the sick and injured even more vulnerable. Seven million Yemenis are currently dependent on humanitarian aid to survive and none living in areas affected by the current violence can receive it while the humanitarian response is on pause. An already catastrophic crisis is being made worse and hundreds of thousands of deaths could ensue in the short term as a result.
I don’t want to leave, knowing that our national staff can’t and nor can the people that depend on humanitarian assistance. None of the international humanitarian staff I know want to leave because we know that the impact will be felt by civilian - people who want no part in this violence and are most affected by it.
We urgently call on all parties for an immediate ceasefire to enable the delivery of aid and safe movement of Yemeni people. The sick and injured must be allowed to access medical care. People must be allowed to get food and water after days in hiding. Civilians with a safe place to go must be allowed to get there. 
Yemen’s humanitarian crisis has not happened organically. It is entirely man-made and must now been undone. We call on all governments with influence over parties to the conflict to make this stop. The blockade must be lifted and Yemen needs a political solution now.

cuttings on Laura Hillenbrand on illness experience

http://emerge.org.au/wp-content/uploads/2014/07/The-New-Yorker-Jul-07_-2003_p56-65.pdf - article in New Yorker - 'A sudden illness - how my life changed'

http://stanmed.stanford.edu/2016summer/leaving-frailty-behind.html

Leaving frailty behind

A conversation with Laura Hillenbrand

This interview was condensed and edited by Paul Costello
Illustration by Lara Tomlin
She is an author of extraordinary success. Laura Hillenbrand’s Seabiscuit and Unbroken are literary phenomenons: Together, there are more than 13 million copies in print, and both have been made into blockbuster motion pictures. Seabiscuit, published in 2001, tells the story of a racehorse that captured America’s heart during the Great Depression. Unbroken, published in 2010, is the biography of World War II hero Louis Zamperini, who survived a bomber crash into the Pacific and more than 2½ years as a prisoner of war in Japan. Hillenbrand wrote the books while besieged by chronic fatigue syndrome, or ME/CFS, which has at times ravaged her like a tidal wave. Stricken in 1987, she has endured vertigo and exhaustion so severe that for many years she was incapacitated and housebound.
Recently, Hillenbrand has made a lot of changes in her medical treatments and in her life. There’s optimism in her voice and a sense of wonderment at new beginnings. A big one is a move across the country to be with her boyfriend in Oregon, where she finds solace in afternoon car rides with views of resplendent Mount Hood.
For this special issue of Stanford Medicine on well-being, we were curious: What does the word “well” mean to someone who has been unwell for so long? Executive editor Paul Costello spoke with Hillenbrand about her illness, her newfound strengths and how she is leaving frailty behind.

Costello: Does the term “being well” register for you?
Hillenbrand: I don’t really think about that as an aspiration, exactly. I think about if I could do this thing, if I could ride a bike for miles, or if I could climb to the top of the Empire State Building. What I think about is a life in which I don’t have to monitor my body. A life in which I’m not constrained in terms of what I want to do and not paying a huge price for what I do. I’m doing much better now than I’ve done in years, and I’ve started riding horses. That’s a great joy to me because it was something I did when I was a healthy person and I was younger.

Costello: Is horseback riding therapeutic for you?
Hillenbrand: Riding is very therapeutic. It’s also therapeutic just as a physical accomplishment. It’s a sport. For decades I didn’t do sports. I maybe could walk around the block. Now I put on my helmet and my boots, and I just feel like I’m more of a normal person. I love that. It’s a marvelous feeling to wed yourself to an animal of such strength.
Costello: It sounds like your life has taken a shift.
Hillenbrand: Everything has come together to give me a little bit of push. I started to test the boundaries and found out, “Well, I could do this. I could do that.” Each one of those things that I did would make me feel like, “Maybe I can try the next thing.” It’s an extremely slow process, and sometimes I overstep and slip backwards. But I keep trying. Once I got out here to Oregon, I got on a bike, which was another thing I was really into when I was healthy, and now I’m starting to ride a bike. Not very far. Not very well. But I’m doing it.
Costello: You moved from Washington, D.C., to Oregon. Did you have to prepare yourself?
Hillenbrand: It took years to get ready to do this. To put you in the perspective of where I was, I had not left Washington, D.C., since 1990 because of vertigo, which has been a problem for me for most of the time I’ve had CFS. It’s not a common kind of vertigo: It has been absolutely constant. It feels like the floor is pitching up and down. It looks like the room is moving around me. My desk is moving. Everything looks and feels like it’s moving. It’s hell.
I began to try to inure myself by getting in a car and riding for five minutes. It would be awful and I would feel terrible. I was so dizzy for an hour afterward, but I just wanted to see: If I keep doing this, can I teach my brain how to tolerate it? I’d go a little longer and a little longer. And over two years, I went from being just miserably dizzy after five minutes to being able to go two hours.
Once I hit two hours, I started thinking maybe I could come across the country. My boyfriend was living in Oregon. I wanted to be with him. I wanted to start a new life. D.C. was not the right place to be for someone with CFS who was very intolerant of heat. I also wanted a simpler world around me because complicated things are difficult with the cognitive problems from CFS.
I was in love and I wanted to be with the man I was in love with. We got an RV and we took a monthlong trip crossing the country and it was a miracle for me. It was the most wondrous thing.

Costello: What did you discover on the trip?
Hillenbrand: Every single thing was beautiful. Every drop of rain, every stretch of highway, every blade of grass was beautiful because I was not in a bed, I was not in a house. People kept saying, “Well, you’re going to have to be bored in the Midwest because it’s not pretty.” I thought it was gorgeous. I was gasping at the grasslands of Kansas. And I thought Illinois was resplendent. And then we went to the Badlands and I’d never seen a canyon before. I just shrieked when I saw it. It was a surprise. My boyfriend didn’t tell me we were going. He said, “Don’t look at the map. I don’t want you to know where we are.” We just pulled up and the land drops away and there are canyons everywhere. I can’t describe how overwhelmed I was by the beauty.
We went to the Black Hills and we went to Spearfish Canyon. We went out to the West Coast. I put my hand in the Pacific Ocean. [laughs] We started at the Atlantic Ocean in Delaware. I got in the water in the Pacific. What I experienced was an overwhelming sense of gratitude because I had been set free. I was not well. I am not well. I am always dealing with symptoms, but I was free enough to have that experience, to see America.

Costello: Love has really changed your life.
Hillenbrand: It’s the biggest thing that got me to take this leap. It was very, very, very risky for me to do this. I could have died on this trip. When I push too far ... at one point, when I tried to take a trip in 1991, I went into shock and very nearly died.
I could have landed in bed for another 10 years. It was so risky, but I just believed that I could do it. I believed in the person I was with. I thought, I have to try. I cannot live my whole life in a room. I can’t do it. I won’t do it. I’m willing to risk everything to escape.

Costello: Can you describe how you experience the illness?
Hillenbrand: The typical experience of it is akin to being bound in plastic so that you can’t move your arms and legs, you can’t speak and be heard. You are suffocating. It closes off the world to you in a most profound way so that all that is left of you is the thoughts in your mind, because you just aren’t capable of doing anything, of interacting with the world at all. There was a period of time where I didn’t leave the house for two years. I was too weak to do it. That is the physical experience of it. You become a purely intellectual thing because you are no longer a physical creature at all.
The parameters of my strength are nothing like that of a normal person. There’s a red line I cannot cross, because to cross it means to plunge into a “crash,” a devastating state of exhaustion in which I can’t stand, sit up, or sometimes even speak.
In terms of what that has given me, I feel like independent of what the cause of suffering is, there is this place that suffering takes you that is common to people suffering from all different kinds of things, serious diseases or terrible grief or all of the things that fell us in our lives.
In writing Unbroken, which is about servicemen at war and prisoners of war and people in horrific states of suffering, I felt like I was able to climb into their bodies and minds maybe better than I would have been if I had just been a regular healthy person.
I felt like I knew what Louis Zamperini felt when he was being held prisoner on Kwajalein Island and having medical experiments done on him by the Japanese. Not that I am comparing my disease to the experience of a prisoner of war. That’s a different and horrible thing that’s inflicted upon you by others. But the quality of the suffering … when he and I would discuss it, he knew I knew something of what he felt. He told me that enabled him to delve more deeply into it with me than he had with other people. He felt like if he told me this story, I would write it down right.
At the end he told me that what I wrote was so true to his experience that he kept having to put the book down and look out the window and tell himself, “I’m here. I’m here. I’m here. I’m not there anymore.”
Costello: Are there any scenes from either of your books that you return to when you are facing a challenge that seems insurmountable?
Hillenbrand: Stanley Pillsbury was the top turret gunner on Louis’ B-24 bomber. There is a very harrowing experience that these men went through when fighting off Zeros [Japanese fighter planes] after bombing Nauru Island.
A Zero was coming at Stanley Pillsbury and he had been shot in the leg with a cannon. His leg was horribly mangled. He was terrified. He was a very quiet and recessive kind of man. He did not have a swaggering kind of personality that you think of in a war hero, but he had this moment where he’s in agony with his leg dangling down and the plane has been hit 600 times by cannon fire and bullet fire. It’s likely to crash.
Somewhere inside himself Stanley found this wondrous strength and he pivoted in his motorized chair and he took aim. He could see the Japanese pilot flying toward him, and he thought, “I have to kill this man.” But he had to do it to save all the men aboard his plane. He fired and he shot down the Zero and he saved everybody on the plane.
That is something I go back to a lot because Stanley had no idea that he had that kind of strength in him, that he could do that. None of us knows what we would really be in these circumstances of extremity. Stanley found out that day. I like to remember that when I feel frightened. When I feel too small for my circumstances, I remember Stanley.

Costello: Your books are beloved. You’ve reached epic fame. How has that outside success impacted you?
Hillenbrand: Having been able to write the books was lifesaving for me. It gave me an ability to connect with the world. It gave me an escape from my body. It enabled me to create things that had importance.
These are not books that the world will turn upon forever. These are stories from history, but they are very inspiring stories, and they do bring joy and relief and peace to people when they read them. That means a great deal to me.
I had lost the ability to connect with the world in any way at all. Even just talking on the phone I couldn’t do much of the time. I was able, though, to write these books and tell these stories, and reach out to people I would never meet all over the world and create something. It validated my life.
It changed the way I thought of myself, also. Most patients will tell you that it’s terribly humiliating to have this particular disease, because it isn’t taken seriously. You are treated with terrible contempt, sometimes by your own family. You lose that respect that you normally receive in conversing with the world because people are really spilling contempt on you all the time.
It gets to you after a while. You start to feel like nothing because you’re told that all the time. That you’re lazy, and that you’re useless. These are words that I heard a lot. When I wrote those books, I proved I wasn’t lazy and I wasn’t useless.

Costello: Were you proving something to yourself?    
Hillenbrand: I was proving what I was. It was really, really hard to write a book with this disease. It’s never easy to write a book, but to do it with vertigo and to do it with exhaustion it took every bit of me. I would do it again because of the self-respect I got out of it.

Costello: Are you angry at the medical community over the disease being so misunderstood?
Hillenbrand: I felt very, very angry for a long time about it, angry with specific doctors who were particularly appalling in their behavior toward me. I was angry over the damage that caused, physically and emotionally.
I don’t feel contempt for the medical community. Different doctors are different people. I got my diagnosis from a wonderful guy, the head of infectious diseases at Johns Hopkins, who was the first person who was willing to say, “You have a serious disease, and the other people who have dismissed you are simply wrong. I don’t know what’s wrong with you, but I believe that you’re very ill.” That took humility for him to say. I am so grateful for it. I walked out of there happy even though he said, “I can’t treat you. I don’t know what to do for you.” But simply telling me, “I respect you, and I have a limit to my understanding of disease,” was a beautiful thing.
My physician in Washington, D.C., would exhaust himself trying to help me, and he would stay with me for hours. He would make house calls because I couldn’t come to him. He was wonderful to me.
I don’t blanket the whole medical community for what some people did back then, and I am treated with much more respect now.

Costello: What gives your life meaning?
Hillenbrand: I want my life to touch the lives of others in a positive way if I can possibly do that. I want to give as much of myself and whatever gifts I have to other people to make the world better if I can. I write with the goal of serving my subjects in terms of telling their stories and trying to illuminate the world a little bit with what those stories have to offer about living and about history. Those are the things that motivate me every day. A weirdly beautiful gift the disease has given me is to appreciate everything in this world, even the things that you simply take for granted if you’re well.

Saturday, December 02, 2017

instagramming knitters

https://www.instagram.com/woolapyk/

https://www.instagram.com/verapaelman/

https://www.instagram.com/sidselsangild/

https://www.instagram.com/satoko.tricot_the/

http://filcolana.dk/en

https://www.ravelry.com/designers/sidsel-sangild


Cutting from the nation re insulin price hikes in US - a medication discovered almost a century earlier


https://www.thenation.com/article/alex-azar-trumps-hhs-pick-has-already-been-a-disaster-for-people-with-diabetes/


'Alex Azar, Trump’s HHS Pick, Has Already Been a Disaster for People With Diabetes

While he was at Eli Lilly, the company more than tripled the price of its best-selling insulin.


Last year The New York Times published an op-edurging the break up of the “insulin racket.” But rather than break it up, Trump has nominated one of its architects, Alex Azar, for secretary of Health and Human Services.
From 2007 to 2017, Azar worked for pharmaceutical giant Eli Lilly. While he was a senior VP, Lilly paid a record $1.415 billion to settle a case on its off-label promotion of the antipsychotic Zyprexa. Rising up the ranks, Azar became president of Lilly USA, the largest division of Eli Lilly, in 2012, a position he held until resigning in January of this year.
During Azar’s tenure, Eli Lilly raised the prices on its insulins in the United States by 20.8 percent in 2014, 16.9 percent in 2015, and 7.5 percent in 2016. Eli Lilly’s biggest seller, Humalog insulin, is now off-patent. But rather than becoming cheaper, Humalog costs more now than when it first came to market in 1996. When Azar started working at Eli Lilly in June 2007, the list price for a vial of Humalog was $74. When he quit in January 2017, it was $269.
At T1International we asked people with type 1 diabetes around the world how much they paid each month to stay alive. The United States topped every country, spending on average $571.69 per month on diabetes costs. Even with insurance, some Americans are spending around half their income on insulin and other supplies.
In fact, price gouging from Eli Lilly and other insulin manufacturers has already had deadly consequences. Shane Patrick Boyle, a founder of Zine Fest Houston, died on March 18 after his GoFundMe campaign to pay for insulin came up $50 short. Alec Raeshawn Smith, age 26, was found dead in his apartment on June 27. He was rationing his insulin after he aged out of his parent’s insurance coverage. The sad fact is more people would be alive today if insulin was affordable for all Americans.
Contrary to pharma propaganda, insulin is neither “new” nor “innovative.” It was developed in Toronto in 1921. The discoverers turned down the chance to create for-profit clinics. Instead, they licensed their creation for $1 (Canadian) a piece. Their recorded reason for doing this was to make sure insulin would be available for all who needed it. Eli Lilly’s was tasked with manufacturing insulin for North America. There was an understanding insulin would be sold at a reasonable price until there was a cure for diabetes.
What difference a century makes! Eli Lilly is currently under investigation by multiple state attorneys general for price fixing. It is also named in a class-action lawsuit that alleges that it colluded with Novo Nordisk and Sanofi to keep the prices in the US insulin market rising. These “Big 3” insulin makers control over 90 percent of the global market and maintain their lock on it in many ways. One is “pay-for-delay schemes,” like when Sanofi paid Eli Lilly to delay the launch of an insulin similar to its Lantus brand. Another is to sue potential competitors for intellectual property infringement, such as when Merck attempted to enter the insulin market in 2016. The companies also funnel money into patient-advocacy groups, both big and small. This might explain the inaction or even outright opposition of these groups on measures that may rein in prices.
At first glance Trump’s decision to appoint Azar is surprising. Public support for lower drug prices is at an all-time high. Why hire a man directly responsible for raising the price of a drug that millions depend on? The reason becomes clear once you review the campaign contributions. Azar’s Lilly spent millions lobbying Congress, the Department of Health and Human Services, spending $5.7 million in 2016 alone. The company has deep ties to the Trump administration. Lilly’s current CEO, David Ricks, was one of the first business leaders to meet with Trump after his inauguration. Ricks has publicly and repeatedly backed Trump’s tax-reform plans. Vice President Mike Pence also knows Azar well from his time as governor of Indiana, where Eli Lilly is headquartered. Clearly the Trump administration and Alex Azar feel they have a friend in each other.
Alex Azar was part of pharma-lobby group Biotechnology Innovation Organization (BIO) until this year. When you ask pharma-lobby groups like BIO to explain why drugs cost so much, they’ll tell you “it’s complicated.”
In fact, it is simple. Drugs cost far too much. There are all sorts of ideas on how to bring prices down. Allow Medicare to negotiate drug prices. Let private citizens buy their drugs abroad. Mandate transparency on the dealings between drug companies, pharmacies, and middlemen called pharmacy benefit managers, as the State of Nevada did this year with SB539, a bill with bipartisan support.
We can expect Alex Azar to pursue none of these options. Looking at his track record, you can bet he will continue to back pharma-friendly approaches. Expect the Orwellian phrase “value-based pricing” to be commonplace. Since insulin literally keeps people alive, the Big 3 insulin producers have already tried to argue that value is a good reason to keep the prices high. The fact that insulin is almost 100 years old and costing pennies on the dollar to be produced means little when next quarter’s revenue is at stake.
Trump has repeatedly called for drug-price reform. Last year he called out big pharma for “getting away with murder.” Yet by nominating Azar he just sent a clear message to industry. It’s open season.
Oppose this nomination.'
James ElliottJames Elliott is a trustee of T1International, a registered UK Charity dedicated to #insulin4all that does not accept pharmaceutical funding